Lithium Controlled-Release and Extended-Release Tablets and ProCentra

In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.

Consumer information for this minor interaction is not currently available. Some minor drug interactions may not be clinically relevant in all patients. Minor drug interactions do not usually cause harm or require a change in therapy. However, your healthcare provider can determine if adjustments to your medications are needed.

The anorectic and stimulatory effects of amphetamines may be inhibited by lithium carbonate. The mechanism of interaction is unknown. Clinicians prescribing the combination should be aware of this potential interaction.

Lithium Controlled-Release and Extended-Release Tablets

Generic Name: lithium

Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR

Synonyms: Lithium

What is Lithium Controlled-Release and Extended-Release Tablets?

ProCentra

Generic Name: dextroamphetamine

Brand name: Dexedrine Spansule, ProCentra, Zenzedi, Dexedrine, Dextrostat, Liquadd

Synonyms: n.a.

What is ProCentra?